A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population.
Semin Arthritis Rheum. 2018 Jul 19;:
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis.
RMD Open. 2018;4(1):e000637
Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity Predicts a Low Probability of Achieving Low Disease Activity at Month 6.
Arthritis Care Res (Hoboken). 2018 Apr 26;:
High Adherence Observed to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over 8 Years.
Arthritis Care Res (Hoboken). 2018 Feb 16;:
Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
Ann Rheum Dis. 2018 Jan 17;:
The Dorsal 4-finger Technique: A Novel Method to Examine Metacarpophalangeal Joints in Patients with Rheumatoid Arthritis.
J Rheumatol. 2018 Jan 15;:
Corrigendum to "Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome" [Clin. Immunol. 168 (2016) 25-29].
Clin Immunol. 2017 Nov 28;:
Overweight and Obesity Reduce the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results from the Canadian Early Arthritis Cohort Study.
Arthritis Care Res (Hoboken). 2017 Nov 30;:
Early Rheumatoid Arthritis Presentation, Treatment and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis.
Arthritis Care Res (Hoboken). 2017 Nov 10;: